<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.bbadva.2021.100004">
         <dct:format>application/xml</dct:format>
         <dct:title>Changes in neurodegeneration-related miRNAs in brains from CAPN1−/− mice</dct:title>
         <dct:creator>Wenyue Su</dct:creator>
         <dct:creator>Xiaoning Bi</dct:creator>
         <dct:creator>Yubin Wang</dct:creator>
         <dct:creator>Michel Baudry</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Calpain-1</rdf:li>
               <rdf:li>Brain</rdf:li>
               <rdf:li>Dicer</rdf:li>
               <rdf:li>miRNA</rdf:li>
               <rdf:li>Neurodegeneration</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>BBA Advances 1 (2021). doi:10.1016/j.bbadva.2021.100004</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>BBA Advances</prism:publicationName>
         <prism:copyright>© 2021 The Author(s). Published by Elsevier B.V.</prism:copyright>
         <dct:publisher>Elsevier B.V.</dct:publisher>
         <prism:issn>2667-1603</prism:issn>
         <prism:volume>1</prism:volume>
         <prism:coverDisplayDate>2021</prism:coverDisplayDate>
         <prism:doi>10.1016/j.bbadva.2021.100004</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.bbadva.2021.100004</prism:url>
         <dct:identifier>doi:10.1016/j.bbadva.2021.100004</dct:identifier>
         <bam:articleNumber>100004</bam:articleNumber>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2021-02-05T13:52:21Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S300.1</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="fla" xml:lang="en" version="5.6">
      <ja:item-info>
         <ja:jid>BBADVA</ja:jid>
         <ja:aid>100004</ja:aid>
         <ce:article-number>100004</ce:article-number>
         <ce:pii>S2667-1603(21)00003-X</ce:pii>
         <ce:doi>10.1016/j.bbadva.2021.100004</ce:doi>
         <ce:copyright type="unknown" year="2021"/>
      </ja:item-info>
      <ja:head>
         <ce:title id="tte0002">Changes in neurodegeneration-related miRNAs in brains from CAPN1<ce:sup loc="post">−/−</ce:sup> mice</ce:title>
         <ce:author-group id="aut0001">
            <ce:author id="au0001"
                       author-id="S266716032100003X-df4868a7ec92630eacbf23609fff5488">
               <ce:given-name>Wenyue</ce:given-name>
               <ce:surname>Su</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/data-curation">Data curation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-original-draft">Writing – original draft</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0002"
                       author-id="S266716032100003X-a9ab4a881d949761eec539105dd2474e">
               <ce:given-name>Xiaoning</ce:given-name>
               <ce:surname>Bi</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0003"
                       author-id="S266716032100003X-811eaacc199d687b622df6f6f72e3b05">
               <ce:given-name>Yubin</ce:given-name>
               <ce:surname>Wang</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/investigation">Investigation</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/data-curation">Data curation</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0004"
                       author-id="S266716032100003X-3ee54d4a18019c24ed0be25aaf1ef7ce">
               <ce:given-name>Michel</ce:given-name>
               <ce:surname>Baudry</ce:surname>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/conceptualization">Conceptualization</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/funding-acquisition">Funding acquisition</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/project-administration">Project administration</ce:contributor-role>
               <ce:contributor-role role="http://credit.niso.org/contributor-roles/writing-review-editing">Writing – review &amp; editing</ce:contributor-role>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0001" type="email" xlink:href="mailto:mbaudry@westernu.edu">mbaudry@westernu.edu</ce:e-address>
            </ce:author>
            <ce:affiliation id="aff0001"
                            affiliation-id="S266716032100003X-cd03d498c5d7ea3e4ee1298299fe7c92">
               <ce:label>a</ce:label>
               <ce:textfn id="cetextfn0001">Graduate College of Biomedical Sciences, United States</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Graduate College of Biomedical Sciences</sa:organization>
                  <sa:country>United States</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0001">aGraduate College of Biomedical Sciences, United States</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0002"
                            affiliation-id="S266716032100003X-ab11fcdcee5102a266ec448f0ee4704e">
               <ce:label>b</ce:label>
               <ce:textfn id="cetextfn0002">College of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, United States</ce:textfn>
               <sa:affiliation>
                  <sa:organization>College of Osteopathic Medicine of the Pacific</sa:organization>
                  <sa:organization>Western University of Health Sciences</sa:organization>
                  <sa:city>Pomona</sa:city>
                  <sa:state>CA</sa:state>
                  <sa:postal-code>91766</sa:postal-code>
                  <sa:country>United States</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0002">bCollege of Osteopathic Medicine of the Pacific, Western University of Health Sciences, Pomona, CA 91766, United States</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor0001">
               <ce:label>⁎</ce:label>
               <ce:text id="cetext0001">Corresponding author.</ce:text>
            </ce:correspondence>
         </ce:author-group>
         <ce:abstract class="author-highlights" id="abs0001" view="all">
            <ce:section-title id="cesectitle0001">Highlights</ce:section-title>
            <ce:abstract-sec id="abss0001" view="all">
               <ce:simple-para id="spara006" view="all">
                  <ce:list id="celist0001">
                     <ce:list-item id="celistitem0001">
                        <ce:label>•</ce:label>
                        <ce:para id="para0001" view="all">Levels of active Dicer were reduced in CANP1<ce:sup loc="post">−/−</ce:sup> mouse brain.</ce:para>
                     </ce:list-item>
                     <ce:list-item id="celistitem0002">
                        <ce:label>•</ce:label>
                        <ce:para id="para0002" view="all">Neurodegeneration-related miRNAs were down-regulated in CANP1<ce:sup loc="post">−/−</ce:sup> mouse brain.</ce:para>
                     </ce:list-item>
                     <ce:list-item id="celistitem0003">
                        <ce:label>•</ce:label>
                        <ce:para id="para0003" view="all">Calpain-1 restored Dicer activity and miRNA expression in CANP1<ce:sup loc="post">−/−</ce:sup> mouse brain.</ce:para>
                     </ce:list-item>
                  </ce:list>
               </ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:abstract class="author" id="abs0002" view="all">
            <ce:section-title id="cesectitle0002">Abstract</ce:section-title>
            <ce:abstract-sec id="abss0002" view="all">
               <ce:simple-para id="spara007" view="all">Calpain-1 knock-out (KO) mice exhibit enhanced susceptibility to neurodegeneration due to the lack of the neuroprotective function of calpain-1. Dicer has been shown to play a fundamental role in the biogenesis of most miRNAs. Here, we identified 45 differentially expressed miRNAs (DE miRNAs) in the brain of calpain-1 KO mice, as compared to wild-type mice. In particular, among all the DE miRNAs, 7 neurodegeneration-related miRNAs were found to be down-regulated in calpain-1 KO mice. We also found that Dicer is cleaved by calpain-1 in mouse brain, which generates an active fragment of Dicer with RNAse III activity and increases miRNA formation. Levels of active Dicer were reduced in brain homogenates from calpain-1 KO mice and incubation with calpain-1 and calcium restored Dicer activity and miRNA expression. Our results indicate that calpain-1 deletion results in decreased levels of active Dicer and changes in neurodegenerative-related miRNAs. These findings could account for some of the pathological changes found in brain of various mammals, including humans, with calpain-1 mutations or down-regulation.</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:abstract class="graphical" id="abs0003" view="all">
            <ce:section-title id="cesectitle0003">Graphical abstract</ce:section-title>
            <ce:abstract-sec id="abss0003" view="all">
               <ce:simple-para id="spara008" view="all">Schematic representation of the effects of calpain-1 down-regulation on miRNA generation. Left. The activation of Dicer by calpain-1-mediated cleavage contributes to miRNA synthesis. Levels of active Dicer and of several miRNAs are decreased in brain of calpain-1 KO mice. Incubation of brain homogenates from calpain-1 KO mice with calpain-1 restores active Dicer and enhances miRNAs synthesis. Red fonts represent miRNAs which were validated by RT-qPCR.  [Display omitted] </ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords class="keyword" id="keys0001" view="all">
            <ce:section-title id="cesectitle0004">Keywords</ce:section-title>
            <ce:keyword id="key0001">
               <ce:text id="cetext0002">Calpain-1</ce:text>
            </ce:keyword>
            <ce:keyword id="key0002">
               <ce:text id="cetext0003">Brain</ce:text>
            </ce:keyword>
            <ce:keyword id="key0003">
               <ce:text id="cetext0004">Dicer</ce:text>
            </ce:keyword>
            <ce:keyword id="key0004">
               <ce:text id="cetext0005">miRNA</ce:text>
            </ce:keyword>
            <ce:keyword id="key0005">
               <ce:text id="cetext0006">Neurodegeneration</ce:text>
            </ce:keyword>
         </ce:keywords>
         <ce:keywords class="abr" id="keys0002" view="all">
            <ce:section-title id="cesectitle0005">Abbreviations</ce:section-title>
            <ce:keyword id="key0006">
               <ce:text id="cetext0007">DE miRNA</ce:text>
               <ce:keyword id="key7a">
                  <ce:text id="cetext7a">differentially expressed miRNAs</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0007">
               <ce:text id="cetext0008">WT</ce:text>
               <ce:keyword id="key8a">
                  <ce:text id="cetext8a">wild-type</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0008">
               <ce:text id="cetext0009">KO</ce:text>
               <ce:keyword id="key9a">
                  <ce:text id="cetext9a">knock-out</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0009">
               <ce:text id="cetext0010">CPM</ce:text>
               <ce:keyword id="key10a">
                  <ce:text id="cetext10a">count-per-million</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0010">
               <ce:text id="cetext0011">DEG</ce:text>
               <ce:keyword id="key11a">
                  <ce:text id="cetext11a">differentially expressed genes</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0011">
               <ce:text id="cetext0012">RISC</ce:text>
               <ce:keyword id="key12a">
                  <ce:text id="cetext12a">RNA-induced silencing complex</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0012">
               <ce:text id="cetext0013">TF</ce:text>
               <ce:keyword id="key13a">
                  <ce:text id="cetext13a">transcription factors</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0013">
               <ce:text id="cetext0014">KEGG</ce:text>
               <ce:keyword id="key14a">
                  <ce:text id="cetext14a">Kyoto Encyclopedia of Genes and Genomes</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0014">
               <ce:text id="cetext0015">PCA</ce:text>
               <ce:keyword id="key15a">
                  <ce:text id="cetext15a">principal component analysis</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0015">
               <ce:text id="cetext0016">PC1</ce:text>
               <ce:keyword id="key16a">
                  <ce:text id="cetext16a">principal component 1</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0016">
               <ce:text id="cetext0017">PC2</ce:text>
               <ce:keyword id="key17a">
                  <ce:text id="cetext17a">principal component 2</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0017">
               <ce:text id="cetext0018">AD</ce:text>
               <ce:keyword id="key18a">
                  <ce:text id="cetext18a">Alzheimer's disease</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0018">
               <ce:text id="cetext0019">PD</ce:text>
               <ce:keyword id="key19a">
                  <ce:text id="cetext19a">Parkinson's disease</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0019">
               <ce:text id="cetext0020">HD</ce:text>
               <ce:keyword id="key20a">
                  <ce:text id="cetext20a">Huntington's disease</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0020">
               <ce:text id="cetext0021">ALS</ce:text>
               <ce:keyword id="key21a">
                  <ce:text id="cetext21a">Amyotrophic lateral sclerosis</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0021">
               <ce:text id="cetext0022">RT-qPCR</ce:text>
               <ce:keyword id="key22a">
                  <ce:text id="cetext22a">quantitative reverse transcription PCR</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0022">
               <ce:text id="cetext0023">3’ UTR</ce:text>
               <ce:keyword id="key23a">
                  <ce:text id="cetext23a">3’ untranslated region</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0023">
               <ce:text id="cetext0024">5’ UTR</ce:text>
               <ce:keyword id="key24a">
                  <ce:text id="cetext24a">5’ untranslated region</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0024">
               <ce:text id="cetext0025">SNPs</ce:text>
               <ce:keyword id="key25a">
                  <ce:text id="cetext25a">single-nucleotide polymorphisms</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="key0025">
               <ce:text id="cetext0026">poly-miRTSs</ce:text>
               <ce:keyword id="key26a">
                  <ce:text id="cetext26a">polymorphisms/mutations in miRNA target sites</ce:text>
               </ce:keyword>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
